SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Univec (UNVC)
UNVC 0.00270+3.8%9:33 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phyco who started this subject7/19/2002 8:32:02 AM
From: scott_jiminez   of 181
 
This may direct some eyes towrds Univec.

In today's New York Times:

===============
Questioning $1 Million Fee in a Needle Deal
By BARRY MEIER with MARY WILLIAMS WALSH

July 19, 2002

A group that buys medical supplies for a third of the nation's hospitals received two highly unusual payments
totaling $1.1 million from a company that had received the exclusive right to market hypodermic needles and other products to the group's hospitals.

Several legal experts said in interviews that they found the payments to the buying group, Novation, troubling
because they might be construed as kickbacks if they were used to obtain business.

In one case, Novation said the nation's biggest needle maker, Becton Dickinson & Company, paid it $1 million in "special marketing" fees in 2000 in connection with a three-year contract for syringes and needles. The payment came at a time when health care workers and others were saying that some Becton Dickinson products did not provide enough protection for medical workers against accidental needle sticks, which can transmit pathogens like the AIDS virus. Smaller manufacturers were also beginning to challenge Becton Dickinson with new safety products.

<abridged>
===============
nytimes.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext